Zhengxia Chen

This inventor holds 20 USPTO granted patents and 6 published patent applications, plus 6 CIPO patents and 14 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Cgenetech (Suzhou, China) Co., Ltd., Guangdong Raynovent Biotech Co., Ltd.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zhengxia Chen. Retrieved from https://idiyas.com/inventor/zhengxia-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 6 (Patent Applications = 4)

EPO Patents = 14 (Patent Applications = 20)

Average Co-Inventor Count = 6.7

ph-index = 3

Forward Citations = 19(Granted Patents)

Location History:

Dongguan, CN (2020)
Shanghai, CN (2016 - 2024)

Company Filing History:

3 out of 2,405

Merck Sharp + Dohme Corp.

patents

2 out of 5

Cgenetech (Suzhou, China) Co., Ltd.

patents

2 out of 13

Guangdong Raynovent Biotech Co., Ltd.

patents

4. 2 out of 4

Harbin Zhenbao Pharmaceutical Co., Ltd.

patents

5. 2 out of 72

Medshine Discovery Inc.

patents

6. 2 out of 2

Novaonco Js Therapeutics Co., Ltd.

patents

7. 1 out of 1

Chongqing Pharmaceutical Industrial Research Institute Co. Ltd.

patent

8. 1 out of 7

Chongqing Pharmaceutical Research Institute Co., Ltd

patents

9. 1 out of 1

Cspc Zhongqi Pharmaceuticall Technology (Shijiazhuang) Co., Ltd.

patent

10. 1 out of 1

Guangdong Xianqiang Pharmaceutical Co., Ltd

patent

11. 1 out of 5

Guangdong Zhongsheng Pharmaceutical Co., Ltd

patents

12. 1 out of 2

Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory

patents

13. 1 out of 1

Shenzhen Lingfang Biotech Co., Ltd.

patent

14. 1 out of 2

Wuxi Life Fountain Biotech Co., Ltd

17. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12643861 - Crystalline form of fluvatinib or fluvatinib methanesulfonate and preparation method therefor (2026-06-02),

2. 12606540 - Triazolone compound (2026-04-21),

3. 12509440 - Fluorovinylbenzamide compound as PD-L1 immunomodulator (2025-12-30),

4. 12378241 - Pyridine derivative as FGFR and VEGFR dual inhibitors (2025-08-05),

5. 12325703 - Fused ring compound as FGFR and VEGFR dual inhibitor (2025-06-10),

6. 12312347 - Azaindole derivative and use thereof as FGFR and C-Met inhibitor (2025-05-27),

7. 12297197 - Pyrazolopyridine compound as RET inhibitor and application thereof (2025-05-13),

8. 12152013 - Vinylpyridine carboxamide compound as PD-L1 immunomodulator (2024-11-26),

9. 11919898 - Crystal form of azaindole derivative and use thereof (2024-03-05),

10. 11440903 - Salt form and crystal form of compound as FGFR4 inhibitor and preparation method thereof (2022-09-13),

11. 11236094 - Substituted pyrrolo[2,1-f][1,2,4]triazines as FGFR inhibitors (2022-02-01),

12. 11161817 - Quinoline derivative and use thereof as tyrosine kinase inhibitor (2021-11-02),

13. 11078194 - Salt form and crystal form serving as FGFR and VEGFR inhibitor compounds, and preparation method therefor (2021-08-03),

14. 11008292 - FGFR4 inhibitor and preparation method and use thereof (2021-05-18),

15. 10766862 - Crystal form and salt form of and preparation method for tyrosine kinase inhibitor (2020-09-08),

Title: Zhengxia Chen - Pioneering Inventor from Shanghai

Introduction: Zhengxia Chen is a renowned inventor hailing from Shanghai, China, known for his groundbreaking contributions to various technological fields.

Latest Patents: Zhengxia Chen holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Zhengxia Chen has worked with leading research institutions and multinational companies, consistently pushing the boundaries of technological advancement.

Collaborations: Throughout his career, Zhengxia Chen has collaborated with top universities and innovative startups, fostering a culture of creativity and forward thinking in the industry.

Conclusion: Zhengxia Chen's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a trailblazer in the world of inventions.

Profile summary based on public USPTO records.